Scholarlink

Objectives <p>School-based vaccine programs in Quebec experienced significant disruptions due to the COVID-19 pandemic. Some vaccines offered in schools, such as the human papillomavirus (HPV) vaccine, continue to fall short of the 90% vaccine coverage (VC) target for the routine program. This study aims to assess temporal changes in VC for HPV, compare trends with other vaccines delivered in schools, and examine socioeconomic disparities in HPV VC.</p> Methods <p>We conducted a retrospective cohort study using data from the Quebec Immunization Registry linked with the Quebec Ministry of Education database to compare VC among students in Grades 4 and 9 between the 2019–2020 (pre-pandemic period) and the 2022–2023 school years (post-pandemic period).</p> Results <p>HPV VC ≥ 1 dose for students in Grade 4 declined in 2022–2023 (81.6%) compared with 2019–2020 (86.1%), with persistent inequalities among students living in the most deprived areas, as well as those from neighborhoods with higher proportions of immigrants or non-French/English language spoken at home. In 2022–2023, 90.7% of girls and 88.5% of boys in Grade 9 had received ≥ 1 dose of HPV vaccine. Compared with 2019–2020, VC among girls was 2 percentage points (pp) lower. No decline was observed for the hepatitis A and B vaccine in Grade 4 and the tetanus and diphtheria vaccine in Grade 9, but coverage for the Men-C-C vaccine in Grade 9 was 3.5&#xa0;pp lower in 2022–2023.</p> Conclusion <p>The decline in HPV VC has continued into 2022–2023, with persistent inequalities. Sustained efforts are needed to close the gap and ensure adequate protection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Measuring the long-term impact of the COVID-19 pandemic on HPV vaccination in Quebec, Canada: A cohort study from the Canadian immunization research network

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月26日

查看全文
  • Marilou Kiely,
  • Iulia Gabriela Ionescu,
  • Mourad Dahhou,
  • Ève Dubé,
  • Chantal Sauvageau,
  • Laura Reifferscheid,
  • Dominique Gagnon,
  • Shannon E. MacDonald

摘要

Objectives

School-based vaccine programs in Quebec experienced significant disruptions due to the COVID-19 pandemic. Some vaccines offered in schools, such as the human papillomavirus (HPV) vaccine, continue to fall short of the 90% vaccine coverage (VC) target for the routine program. This study aims to assess temporal changes in VC for HPV, compare trends with other vaccines delivered in schools, and examine socioeconomic disparities in HPV VC.

Methods

We conducted a retrospective cohort study using data from the Quebec Immunization Registry linked with the Quebec Ministry of Education database to compare VC among students in Grades 4 and 9 between the 2019–2020 (pre-pandemic period) and the 2022–2023 school years (post-pandemic period).

Results

HPV VC ≥ 1 dose for students in Grade 4 declined in 2022–2023 (81.6%) compared with 2019–2020 (86.1%), with persistent inequalities among students living in the most deprived areas, as well as those from neighborhoods with higher proportions of immigrants or non-French/English language spoken at home. In 2022–2023, 90.7% of girls and 88.5% of boys in Grade 9 had received ≥ 1 dose of HPV vaccine. Compared with 2019–2020, VC among girls was 2 percentage points (pp) lower. No decline was observed for the hepatitis A and B vaccine in Grade 4 and the tetanus and diphtheria vaccine in Grade 9, but coverage for the Men-C-C vaccine in Grade 9 was 3.5 pp lower in 2022–2023.

Conclusion

The decline in HPV VC has continued into 2022–2023, with persistent inequalities. Sustained efforts are needed to close the gap and ensure adequate protection.